14 results on '"Fernández Garcés, Mar"'
Search Results
2. Influencia de la historia de tabaquismo en la evolución de la hospitalización en pacientes COVID-19 positivos: datos del registro SEMI-COVID-19
- Author
-
Navas Alcántara, María Sierra, primary, Montero Rivas, Lorena, additional, Guisado Espartero, María Esther, additional, Rubio-Rivas, Manuel, additional, Ayuso García, Blanca, additional, Moreno Martinez, Francisco, additional, Ausín García, Cristina, additional, Taboada Martínez, María Luisa, additional, Arnalich Fernández, Francisco, additional, Martínez Murgui, Raúl, additional, Molinos Castro, Sonia, additional, Ramos Muñoz, Maria Esther, additional, Fernández-Garcés, Mar, additional, Carreño Hernandez, Mari Cruz, additional, García García, Gema María, additional, Vázquez Piqueras, Nuria, additional, Abadía-Otero, Jesica, additional, Lajara Villar, Lourdes, additional, Salazar Monteiro, Cristina, additional, Pascual Pérez, María de los Reyes, additional, Perez-Martin, Santiago, additional, Collado-Aliaga, Javier, additional, Antón-Santos, Juan-Miguel, additional, and Lumbreras-Bermejo, Carlos, additional
- Published
- 2022
- Full Text
- View/download PDF
3. C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19
- Author
-
Giner Galvañ, Vicente, Pomares Gómez, Francisco, Quesada, José, Rubio Rivas, Manuel, Tejada Montes, Javier, Baltasar Corral, Jesús, Taboada-Martínez, María Luisa, Sánchez Mesa, Blanca, Arnalich Fernández, Francisco, Corral Beamonte, Esther del, López Sampalo, Almudena, Pesqueira Fontán, Paula, Fernández Garcés, Mar, Gómez Huelgas, Ricardo, Ramos Rincón, José, and SEMI-COVID-19 Network
- Subjects
COVID-19 ,serum albumin ,C-reactive protein ,prognosis ,syndemic ,comorbidity ,Comorbiditat ,Medicine (miscellaneous) ,Comorbidity ,General Biochemistry, Genetics and Molecular Biology - Abstract
(1) Background: C-reactive protein (CRP) and albumin are inflammatory markers. We analyzed the prognostic capacity of serum albumin (SA) and CRP for an outcome comprising mortality, length of stay, ICU admission, and non-invasive mechanical ventilation in hospitalized COVID-19 patients. (2) Methods: We conducted a retrospective cohort study based on the Spanish national SEMI-COVID-19 Registry. Two multivariate logistic models were adjusted for SA, CRP, and their combination. Training and testing samples were used to validate the models. (3) Results: The outcome was present in 41.1% of the 3471 participants, who had lower SA (mean [SD], 3.5 [0.6] g/dL vs. 3.8 [0.5] g/dL; p < 0.001) and higher CRP (108.9 [96.5] mg/L vs. 70.6 [70.3] mg/L; p < 0.001). In the adjusted multivariate model, both were associated with poorer evolution: SA, OR 0.674 (95% CI, 0.551–0.826; p < 0.001); CRP, OR 1.002 (95% CI, 1.001–1.004; p = 0.003). The CRP/SA model had a similar predictive capacity (honest AUC, 0.8135 [0.7865–0.8405]), with a continuously increasing risk and cutoff value of 25 showing the highest predictive capacity (OR, 1.470; 95% CI, 1.188–1.819; p < 0.001). (4) Conclusions: SA and CRP are good independent predictors of patients hospitalized with COVID-19. For the CRP/SA ratio value, 25 is the cutoff for poor clinical course.
- Published
- 2022
4. Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: Results from the SEMI-COVID-19 registry
- Author
-
Navas Alcántara, María Sierra, primary, Montero Rivas, Lorena, additional, Guisado Espartero, María Esther, additional, Rubio-Rivas, Manuel, additional, Ayuso García, Blanca, additional, Moreno Martinez, Francisco, additional, Ausín García, Cristina, additional, Taboada Martínez, María Luisa, additional, Arnalich Fernández, Francisco, additional, Martínez Murgui, Raúl, additional, Molinos Castro, Sonia, additional, Ramos Muñoz, Maria Esther, additional, Fernández-Garcés, Mar, additional, Carreño Hernandez, Mari Cruz, additional, García García, Gema María, additional, Vázquez Piqueras, Nuria, additional, Abadía-Otero, Jesica, additional, Lajara Villar, Lourdes, additional, Salazar Monteiro, Cristina, additional, Pascual Pérez, María de los Reyes, additional, Perez-Martin, Santiago, additional, Collado-Aliaga, Javier, additional, Antón-Santos, Juan-Miguel, additional, and Lumbreras-Bermejo, Carlos, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry
- Author
-
Balaz, David, Wikman Jorgensen, Philip Erick, Galvañ, Vicente Giner, Rubio Rivas, Manuel, de Miguel Campo, Borja, López, Mariam Noureddine, López Caleya, Juan Francisco, Huelgas, Ricardo Gómez, Pesqueira Fontán, Paula María, Bailón, Manuel Méndez, Fernández Garcés, Mar, Fernández Cruz, Ana, García García, Gema María, Rhyman, Nicolás, Corral Gudino, Luis, Rodríguez Mancheño, Aquiles Lozano, De La Chica, María Navarro, Torregrosa García, Andrea, Alcalá, José Nicolás, Díaz Jiménez, Pablo, Royo Trallero, Leticia Esther, Comas Casanova, Pere, Núñez Cortés, Jesús Millán, Casas Rojo, José-Manuel, Balaz, David, Wikman Jorgensen, Philip Erick, Galvañ, Vicente Giner, Rubio Rivas, Manuel, de Miguel Campo, Borja, López, Mariam Noureddine, López Caleya, Juan Francisco, Huelgas, Ricardo Gómez, Pesqueira Fontán, Paula María, Bailón, Manuel Méndez, Fernández Garcés, Mar, Fernández Cruz, Ana, García García, Gema María, Rhyman, Nicolás, Corral Gudino, Luis, Rodríguez Mancheño, Aquiles Lozano, De La Chica, María Navarro, Torregrosa García, Andrea, Alcalá, José Nicolás, Díaz Jiménez, Pablo, Royo Trallero, Leticia Esther, Comas Casanova, Pere, Núñez Cortés, Jesús Millán, and Casas Rojo, José-Manuel
- Abstract
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID-19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7–160) vs. 49.3 (16–109) mg/dL; p < 0.001), ferritin (791 (393–1534) vs. 470 (236–996) µg/dL; p < 0.001), D dimer (750 (430–1400) vs. 617 (345–1180) µg/dL; p < 0.001), and lower Sp02/Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation =90%. Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation =90%., Depto. de Medicina, Fac. de Medicina, TRUE, pub
- Published
- 2021
6. C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19.
- Author
-
Giner-Galvañ, Vicente, Pomares-Gómez, Francisco José, Quesada, José Antonio, Rubio-Rivas, Manuel, Tejada-Montes, Javier, Baltasar-Corral, Jesús, Taboada-Martínez, María Luisa, Sánchez-Mesa, Blanca, Arnalich-Fernández, Francisco, Del Corral-Beamonte, Esther, López-Sampalo, Almudena, Pesqueira-Fontán, Paula María, Fernández-Garcés, Mar, Gómez-Huelgas, Ricardo, and Ramos-Rincón, José Manuel
- Subjects
BLOOD proteins ,SERUM albumin ,COVID-19 ,C-reactive protein ,PROGNOSIS - Abstract
(1) Background: C-reactive protein (CRP) and albumin are inflammatory markers. We analyzed the prognostic capacity of serum albumin (SA) and CRP for an outcome comprising mortality, length of stay, ICU admission, and non-invasive mechanical ventilation in hospitalized COVID-19 patients. (2) Methods: We conducted a retrospective cohort study based on the Spanish national SEMI-COVID-19 Registry. Two multivariate logistic models were adjusted for SA, CRP, and their combination. Training and testing samples were used to validate the models. (3) Results: The outcome was present in 41.1% of the 3471 participants, who had lower SA (mean [SD], 3.5 [0.6] g/dL vs. 3.8 [0.5] g/dL; p < 0.001) and higher CRP (108.9 [96.5] mg/L vs. 70.6 [70.3] mg/L; p < 0.001). In the adjusted multivariate model, both were associated with poorer evolution: SA, OR 0.674 (95% CI, 0.551–0.826; p < 0.001); CRP, OR 1.002 (95% CI, 1.001–1.004; p = 0.003). The CRP/SA model had a similar predictive capacity (honest AUC, 0.8135 [0.7865–0.8405]), with a continuously increasing risk and cutoff value of 25 showing the highest predictive capacity (OR, 1.470; 95% CI, 1.188–1.819; p < 0.001). (4) Conclusions: SA and CRP are good independent predictors of patients hospitalized with COVID-19. For the CRP/SA ratio value, 25 is the cutoff for poor clinical course. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Severity scores in COVID-19 pneumonia: a multicenter, retrospective, cohort study
- Author
-
Artero, Arturo, Madrazo, Manuel, Fernández-Garcés, Mar, Muiño Miguez, Antonio, González García, Andrés, Crestelo Vieitez, Anxela, García Guijarro, Elena, Fonseca Aizpuru, Eva María, García Gómez, Miriam, Areses Manrique, María, Martinez Cilleros, Carmen, Fidalgo Moreno, María Del Pilar, Loureiro Amigo, José, Gil Sánchez, Ricardo, Rabadán Pejenaute, Elisa, Abella Vázquez, Lucy, Cañizares Navarro, Ruth, Solís Marquínez, Marta Nataya, Carrasco Sánchez, Francisco Javier, González Moraleja, Julio, Montero Rivas, Lorena, Escobar Sevilla, Joaquín, Martín Escalante, María Dolores, Gómez-Huelgas, Ricardo, Ramos-Rincón, José Manuel, and SEMI-COVID-19 Network
- Subjects
Male ,community-acquired pneumonia ,Organ Dysfunction Scores ,medicine.medical_treatment ,01 natural sciences ,Severity of Illness Index ,law.invention ,Cohort Studies ,0302 clinical medicine ,qSOFA ,Community-acquired pneumonia ,law ,PSI ,030212 general & internal medicine ,Hospital Mortality ,Original Research ,CURB-65 ,food and beverages ,Prognosis ,Intensive care unit ,Community-Acquired Infections ,Intensive Care Units ,Viral pneumonia ,Female ,COVID-19 ,COVID-19, CURB-65, PSI, community-acquired pneumonia, qSOFA ,medicine.medical_specialty ,Communicable Diseases ,03 medical and health sciences ,Internal medicine ,Internal Medicine ,medicine ,Humans ,0101 mathematics ,Aged ,Retrospective Studies ,Mechanical ventilation ,Receiver operating characteristic ,business.industry ,SARS-CoV-2 ,fungi ,010102 general mathematics ,Retrospective cohort study ,Pneumonia ,medicine.disease ,business - Abstract
BACKGROUND: Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been comprehensively assessed. OBJECTIVE: To compare severity scores used for community-acquired pneumonia to identify high-risk patients with COVID-19 pneumonia. DESIGN: PSI, CURB-65, qSOFA, and MuLBSTA, a new score for viral pneumonia, were calculated on admission to hospital to identify high-risk patients for in-hospital mortality, admission to an intensive care unit (ICU), or use of mechanical ventilation. Area under receiver operating characteristics curve (AUROC), sensitivity, and specificity for each score were determined and AUROC was compared among them. PARTICIPANTS: Patients with COVID-19 pneumonia included in the SEMI-COVID-19 Network. KEY RESULTS: We examined 10,238 patients with COVID-19. Mean age of patients was 66.6 years and 57.9% were males. The most common comorbidities were as follows: hypertension (49.2%), diabetes (18.8%), and chronic obstructive pulmonary disease (12.8%). Acute respiratory distress syndrome (34.7%) and acute kidney injury (13.9%) were the most common complications. In-hospital mortality was 20.9%. PSI and CURB-65 showed the highest AUROC (0.835 and 0.825, respectively). qSOFA and MuLBSTA had a lower AUROC (0.728 and 0.715, respectively). qSOFA was the most specific score (specificity 95.7%) albeit its sensitivity was only 26.2%. PSI had the highest sensitivity (84.1%) and a specificity of 72.2%. CONCLUSIONS: PSI and CURB-65, specific severity scores for pneumonia, were better than qSOFA and MuLBSTA at predicting mortality in patients with COVID-19 pneumonia. Additionally, qSOFA, the simplest score to perform, was the most specific albeit the least sensitive.
- Published
- 2020
8. COVID ‐19 in older adults: What are the differences with younger patients?
- Author
-
Gómez‐Belda, Ana B, primary, Fernández‐Garcés, Mar, additional, Mateo‐Sanchis, Elisabeth, additional, Madrazo, Manuel, additional, Carmona, Mar, additional, Piles‐Roger, Laura, additional, and Artero, Arturo, additional
- Published
- 2020
- Full Text
- View/download PDF
9. Severity scores in COVID-19 pneumonia: a multicenter, retrospective, cohort study
- Author
-
Artero, Arturo, primary, Madrazo, Manuel, additional, Fernández-Garcés, Mar, additional, Miguez, Antonio Muñoz, additional, García, Andrés González, additional, Vieitez, Anxela Crestelo, additional, Guijarro, Elena García, additional, Aizpuru, Eva María Fonseca, additional, Gómez, Miriam García, additional, Manrique, María Areses, additional, Cilleros, Carmen Martinez, additional, Moreno, María del Pilar Fidalgo, additional, Amigo, Jose Loureiro, additional, Sánchez, Ricardo Gil, additional, Pejenaute, Elisa Rabadán, additional, Vázquez, Lucy Abella, additional, Navarro, Ruth Cañizares, additional, Marquínez, Marta Nataya Solís, additional, Sánchez, Francisco Javier Carrasco, additional, Moraleja, Julio González, additional, Rivas, Lorena Montero, additional, Sevilla, Joaquin Escobar, additional, Escalante, María Dolores Martín, additional, Gómez-Huelgas, Ricardo, additional, and Ramos-Rincon, Jose-Manuel, additional
- Published
- 2020
- Full Text
- View/download PDF
10. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study.
- Author
-
Artero, Arturo, Madrazo, Manuel, Fernández-Garcés, Mar, Muiño Miguez, Antonio, González García, Andrés, Crestelo Vieitez, Anxela, García Guijarro, Elena, Fonseca Aizpuru, Eva María, García Gómez, Miriam, Areses Manrique, María, Martinez Cilleros, Carmen, Fidalgo Moreno, María del Pilar, Loureiro Amigo, José, Gil Sánchez, Ricardo, Rabadán Pejenaute, Elisa, Abella Vázquez, Lucy, Cañizares Navarro, Ruth, Solís Marquínez, Marta Nataya, Carrasco Sánchez, Francisco Javier, and González Moraleja, Julio
- Subjects
COVID-19 ,OBSTRUCTIVE lung diseases ,ACUTE kidney failure ,ADULT respiratory distress syndrome ,RECEIVER operating characteristic curves - Abstract
Background: Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been comprehensively assessed. Objective: To compare severity scores used for community-acquired pneumonia to identify high-risk patients with COVID-19 pneumonia. Design: PSI, CURB-65, qSOFA, and MuLBSTA, a new score for viral pneumonia, were calculated on admission to hospital to identify high-risk patients for in-hospital mortality, admission to an intensive care unit (ICU), or use of mechanical ventilation. Area under receiver operating characteristics curve (AUROC), sensitivity, and specificity for each score were determined and AUROC was compared among them. Participants: Patients with COVID-19 pneumonia included in the SEMI-COVID-19 Network. Key results: We examined 10,238 patients with COVID-19. Mean age of patients was 66.6 years and 57.9% were males. The most common comorbidities were as follows: hypertension (49.2%), diabetes (18.8%), and chronic obstructive pulmonary disease (12.8%). Acute respiratory distress syndrome (34.7%) and acute kidney injury (13.9%) were the most common complications. In-hospital mortality was 20.9%. PSI and CURB-65 showed the highest AUROC (0.835 and 0.825, respectively). qSOFA and MuLBSTA had a lower AUROC (0.728 and 0.715, respectively). qSOFA was the most specific score (specificity 95.7%) albeit its sensitivity was only 26.2%. PSI had the highest sensitivity (84.1%) and a specificity of 72.2%. Conclusions: PSI and CURB-65, specific severity scores for pneumonia, were better than qSOFA and MuLBSTA at predicting mortality in patients with COVID-19 pneumonia. Additionally, qSOFA, the simplest score to perform, was the most specific albeit the least sensitive. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. COVID‐19 in older adults: What are the differences with younger patients?
- Author
-
Gómez‐Belda, Ana B, Fernández‐Garcés, Mar, Mateo‐Sanchis, Elisabeth, Madrazo, Manuel, Carmona, Mar, Piles‐Roger, Laura, and Artero, Arturo
- Subjects
- *
IMMUNOGLOBULIN analysis , *ACUTE kidney failure , *AGE distribution , *COGNITION disorders , *CONFIDENCE intervals , *COUGH , *CREATINE kinase , *CREATININE , *FEVER , *HOSPITAL care , *INTELLECT , *LACTATE dehydrogenase , *MEDICAL records , *MYALGIA , *SCIENTIFIC observation , *OXYGEN in the body , *POLYMERASE chain reaction , *ADULT respiratory distress syndrome , *RISK assessment , *SEROLOGY , *COMORBIDITY , *SYMPTOMS , *PREDICTIVE tests , *RETROSPECTIVE studies , *REVERSE transcriptase polymerase chain reaction , *FIBRIN fibrinogen degradation products , *DESCRIPTIVE statistics , *ACQUISITION of data methodology , *ODDS ratio , *COVID-19 , *DISEASE risk factors , *OLD age ,MORTALITY risk factors - Abstract
Aim: The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID‐19), in comparison with those of younger patients, and to identify risk factors for mortality. Methods: A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID‐19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic medical records. Results: The dataset comprised 340 patients. Of them, 152 (44.6%) were aged >70 years. Comorbidities were more common in the older groups. Confusion was more common in older adults, whereas typical symptoms of COVID‐19, such as fever, cough and myalgia, were less common. Oxygen saturation ≤93% on room air, neutrophilia, D‐dimer >0.5 μg/mL, creatinine >1.5 mg/dL, lactate dehydrogenase ≥250 U/L and elevation of creatine kinase were higher in the older adult groups. Complications during hospitalization, such as acute respiratory distress syndrome (53.3% vs 33.2%, P < 0.001), acute kidney injury (11.8% vs 5.3%; P = 0.030) and mortality (28.9% vs 6.5%; P < 0.001) were more common in patients aged >70 years. Oxygen saturation ≤93% on room air on admission was a predictor of mortality (odds ratio 11.65, 95% confidence interval 3.26–41.66, P < 0.001) in patients aged >70 years. Conclusions: Older adults with COVID‐19 have more atypical presentation, more complications and higher mortality. Oxygen saturation ≤93% on room air on admission is a predictive factor of death. Geriatr Gerontol Int 2021; 21: 60–65. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Influencia de la historia de tabaquismo en la evolución de la hospitalización en pacientes COVID-19 positivos: datos del registro SEMI-COVID-19
- Author
-
Navas Alcántara, María Sierra, Montero Rivas, Lorena, Guisado Espartero, María Esther, Rubio-Rivas, Manuel, Ayuso García, Blanca, Moreno Martinez, Francisco, Ausín García, Cristina, Taboada Martínez, María Luisa, Arnalich Fernández, Francisco, Martínez Murgui, Raúl, Molinos Castro, Sonia, Ramos Muñoz, Maria Esther, Fernández-Garcés, Mar, Carreño Hernandez, Mari Cruz, García García, Gema María, Vázquez Piqueras, Nuria, Abadía-Otero, Jesica, Lajara Villar, Lourdes, Salazar Monteiro, Cristina, Pascual Pérez, María de los Reyes, Perez-Martin, Santiago, Collado-Aliaga, Javier, Antón-Santos, Juan-Miguel, and Lumbreras-Bermejo, Carlos
- Abstract
El tabaquismo puede tener un papel importante en la infección por SARS-CoV-2 y en el curso de la enfermedad. Los estudios previos muestran resultados contradictorios o no concluyentes sobre la prevalencia de fumar y la severidad en la enfermedad por coronavirus (COVID-19).
- Published
- 2021
- Full Text
- View/download PDF
13. Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry.
- Author
-
Balaz D, Wikman-Jorgensen PE, Galvañ VG, Rubio-Rivas M, de Miguel Campo B, López MN, Caleya JFL, Huelgas RG, Fontán PMP, Bailón MM, Fernández-Garcés M, Cruz AF, García GMG, Rhyman N, Corral-Gudino L, Rodríguez-Mancheño AL, De La Chica MN, García AT, Alcalá JN, Jiménez PD, Trallero LER, Casanova PC, Núñez-Cortés JM, Casas-Rojo JM, and On Behalf Of The Semi-Covid-Network
- Abstract
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations., Material and Methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID-19 Registry from March to November 2020., Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7-160) vs. 49.3 (16-109) mg/dL; p < 0.001), ferritin (791 (393-1534) vs. 470 (236-996) µg/dL; p < 0.001), D dimer (750 (430-1400) vs. 617 (345-1180) µg/dL; p < 0.001), and lower Sp0
2 /Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation =90%., Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation =90%.- Published
- 2021
- Full Text
- View/download PDF
14. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study.
- Author
-
Artero A, Madrazo M, Fernández-Garcés M, Muiño Miguez A, González García A, Crestelo Vieitez A, García Guijarro E, Fonseca Aizpuru EM, García Gómez M, Areses Manrique M, Martinez Cilleros C, Fidalgo Moreno MDP, Loureiro Amigo J, Gil Sánchez R, Rabadán Pejenaute E, Abella Vázquez L, Cañizares Navarro R, Solís Marquínez MN, Carrasco Sánchez FJ, González Moraleja J, Montero Rivas L, Escobar Sevilla J, Martín Escalante MD, Gómez-Huelgas R, and Ramos-Rincón JM
- Subjects
- Aged, Cohort Studies, Female, Hospital Mortality, Humans, Intensive Care Units, Male, Organ Dysfunction Scores, Prognosis, Retrospective Studies, SARS-CoV-2, Severity of Illness Index, COVID-19, Communicable Diseases, Community-Acquired Infections diagnosis, Community-Acquired Infections epidemiology, Pneumonia diagnosis, Pneumonia epidemiology
- Abstract
Background: Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been comprehensively assessed., Objective: To compare severity scores used for community-acquired pneumonia to identify high-risk patients with COVID-19 pneumonia., Design: PSI, CURB-65, qSOFA, and MuLBSTA, a new score for viral pneumonia, were calculated on admission to hospital to identify high-risk patients for in-hospital mortality, admission to an intensive care unit (ICU), or use of mechanical ventilation. Area under receiver operating characteristics curve (AUROC), sensitivity, and specificity for each score were determined and AUROC was compared among them., Participants: Patients with COVID-19 pneumonia included in the SEMI-COVID-19 Network., Key Results: We examined 10,238 patients with COVID-19. Mean age of patients was 66.6 years and 57.9% were males. The most common comorbidities were as follows: hypertension (49.2%), diabetes (18.8%), and chronic obstructive pulmonary disease (12.8%). Acute respiratory distress syndrome (34.7%) and acute kidney injury (13.9%) were the most common complications. In-hospital mortality was 20.9%. PSI and CURB-65 showed the highest AUROC (0.835 and 0.825, respectively). qSOFA and MuLBSTA had a lower AUROC (0.728 and 0.715, respectively). qSOFA was the most specific score (specificity 95.7%) albeit its sensitivity was only 26.2%. PSI had the highest sensitivity (84.1%) and a specificity of 72.2%., Conclusions: PSI and CURB-65, specific severity scores for pneumonia, were better than qSOFA and MuLBSTA at predicting mortality in patients with COVID-19 pneumonia. Additionally, qSOFA, the simplest score to perform, was the most specific albeit the least sensitive.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.